8

7

6

5

4

3

2

1

0

-

$

,

.

9

8

7

6

5

4

3

2

1

0

-

$

,

.

Why Robinhood?

You can buy or sell Zymeworks and other stocks, options, ETFs, and crypto commission-free!

About

Zymeworks Inc., also called Zymeworks, is a clinical-stage biopharmaceutical company, which engages in the discovery, development and commercialization of biotherapeutics. Its product, ZW25 and ZW49 are a bispecific antibody that cans two non-overlapping epitopes. Read More The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani, and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.

Collections

Technology

Health

Pharmaceutical

Medical

Biopharmaceutical

2017 IPO

Canada

North America

News

Financial PostMay 23

Zymeworks Announces Corporate Update Conference Call

VANCOUVER, British Columbia — Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that it will host a webcast and conference call to discuss progress on its 2019 corporate priorities, including clinical development plans for its lead therapeutic candidates as well as recently announced and established corporate partnerships.
Zymeworks will host a webcast and conference call on Wednesday, May 29, 2019 at 8:30am ET (5:30am PT...

1

Seeking AlphaMay 16

GSK expands collaboration with Zymeworks

GlaxoSmithKline (NYSE:GSK) has expanded the scope of its 2016 licensing and collaboration partnership with Zymeworks (NYSE:ZYME), now enabling access to the latter's heavy-light chain pairing technology which is part of its Azymetric platform.

33

Yahoo FinanceMay 9

Is Zymeworks Inc. A Good Stock To Buy?

Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.

24

Price Paid on Robinhood

12% Higher

Right Now

52 Week Low

$10.72

Average Price Paid

$15.74

52 Week High

$29.00

Earnings

-$0.83

-$0.13

$0.58

$1.28

Q3 2017

Q4 2017

Q1 2018

Q2 2018

Q3 2018

Q4 2018

Q1 2019

Q2 2019

Estimated

—

Actual

Expected Jul 31, After Hours

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy ZYME

Shares

Market Price$17.64

Commissions$0.00

Sign up for a Robinhood Account to buy or sell Zymeworks stock and options commission-free.